Exact Sciences logo

EXAS - Exact Sciences News Story

$107.14 3.8  3.7%

Last Trade - 19/10/20

Sector
Healthcare
Size
Large Cap
Market Cap £12.02bn
Enterprise Value £12.28bn
Revenue £875.9m
Position in Universe 587th / 6403

BRIEF-Exact Sciences Announces Publication Of Results Highlighting Performance Of Oncotype DX Genomic Prostate Score Result In Prostate Cancer

Tue 16th June, 2020 1:16pm
June 16 (Reuters) - Exact Sciences Corp  EXAS.O :
    * EXACT SCIENCES CORP -  ANNOUNCED PUBLICATION OF RESULTS
HIGHLIGHTING PERFORMANCE OF ONCOTYPE DX GENOMIC PROSTATE SCORE
RESULT IN PROSTATE CANCER

Source text for Eikon:  ID:nPn9XNXxDa 
Further company coverage:  EXAS.O 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.